Jonathan Jan Ilve Thorsen

Jonathan Jan Ilve Thorsen

ORCID: 0000-0003-0200-0461

Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2024
  2. Published

    Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages

    Dion, M. B., Shah, S. A., Deng, Ling, Thorsen, Jonathan Jan Ilve, Stokholm, Jakob, Krogfelt, K. A., Schjørring, S., Horvath, P., Allard, A., Nielsen, Dennis Sandris, Petit, M. A. & Moineau, S., 2024, In: The ISME Journal. 18, 1, 9 p., wrae005.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. E-pub ahead of print

    Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study

    Ring, H. C., Thorsen, Jonathan Jan Ilve, Kirby, B., Ingram, J. R., Rosenø, N. A. L., Holgersen, N., Nielsen, V. W., Nikolai Thein Aagaard, D., Maul, J., Wu, J. J., Thyssen, Jacob Pontoppidan, Egeberg, Alexander & Thomsen, Simon Francis, 2024, (E-pub ahead of print) In: British Journal of Dermatology, Supplement.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

ID: 215672837